This document discusses testing iminosugars and aminocyclitols as pharmacological chaperones for mutated glucocerebrosidase enzymes associated with Gaucher disease. The study found that NN-DNJ, NB-DNJ, and C4Ph increased the activity of mutated enzymes in transfected COS-7 cells, and that NN-DNJ and C10 increased activity in patient fibroblasts. These results support the potential use of chemical chaperones as a therapeutic approach for Gaucher disease, but developing and analyzing new compounds is still needed.